title: Alzheimer's imaging agents struggle to find a market outside trials.
authors.forename: Sarah C P
authors.initials: SC
authors.lastname: Williams
mesh_terms: D000544:Alzheimer Disease / Q000000981:diagnostic imaging*; D000814:Aniline Compounds / Q000191:economics*; D052160:Benzothiazoles / Q000191:economics*; D002986:Clinical Trials as Topic; D003937:Diagnosis, Differential; D018450:Disease Progression; D017277:Drug Approval; D004363:Drug Utilization / Q000191:economics; D006801:Humans; D040541:Marketing; D049268:Positron-Emission Tomography / Q000191:economics / Q000379:methods; D011849:Radioactive Tracers; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000814:Aniline Compounds; D052160:Benzothiazoles; D011849:Radioactive Tracers; C581552:flutemetamol